Savara Inc — Director's Dealing 2012

May 11, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADVENTRX PHARMACEUTICALS INC (ANX)
CIK: 0001160308
Period of Report: 2012-05-09

Reporting Person: RAMSAY DAVID A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-05-09	Common Stock	P	10000	$0.55	Acquired	10000	Direct
2012-05-10	Common Stock	P	40000	$0.5653	Acquired	50000	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions executed by a broker-dealer at prices ranging from $0.5600 to $0.5690, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.